Evaluating the Blood-Brain Barrier Bioavailability and in vivo Efficacy Potential of a Novel TAK1 Inhibitor Targeting Chronic Pain
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Eydis Bio Inc.
Start Date
October 1, 2021
End Date
August 31, 2022
Administered By
Pharmacology & Cancer Biology
Awarded By
Eydis Bio Inc.
Start Date
October 1, 2021
End Date
August 31, 2022